Bite Back – the Shark Bite Biz Podcast is Now Available to Help Businesses Grow and Pivot in This Changing Coronavirus World

PHILADELPHIA, August 26, 2020 (Newswire.com) – David Strausser, a subject matter expert helping businesses grow via the promise of technology, today is announcing the launch of his new business-focused podcast “Shark Bite Biz” (http://www.SharkBiteBiz.com) to help grow business in the roaring ’20s The podcast offers two episodes a week, Monday and Thursday at 6 a.m. EST, and […]

Continue Reading

Bite Back – the Shark Bite Biz Podcast is Now Available to Help Businesses Grow and Pivot in This Changing Coronavirus World

PHILADELPHIA, August 26, 2020 (Newswire.com) – David Strausser, a subject matter expert helping businesses grow via the promise of technology, today is announcing the launch of his new business-focused podcast “Shark Bite Biz” (http://www.SharkBiteBiz.com) to help grow business in the roaring ’20s The podcast offers two episodes a week, Monday and Thursday at 6 a.m. EST, and […]

Continue Reading

Almost 3,500 Health Experts Sign Letter Supporting Dr. Fauci

As Dr. Anthony Fauci has become “uninvited” to President Donald Trump solo-act White House coronavirus task force daily briefings, thousands of public health experts have written a letter to express their support for the longtime infectious disease leader. “This week and last, the White House mounted a campaign to discredit one of our nation’s leading scientific experts, Dr. […]

Continue Reading

AstraZeneca Denies Fast-Tracking Vaccine for White House

Pharmaceutical firm AstraZeneca says it has not had any discussions with any U.S. government officials about an emergency use authorization for its coronavirus vaccine, Politico reports. The company’s statement comes a day after the Financial Times reported the White House would consider how to grant an emergency use of the AstraZeneca vaccine if a late-stage clinical trial currently taking […]

Continue Reading

AstraZeneca Denies Fast-Tracking Vaccine for White House

Pharmaceutical firm AstraZeneca says it has not had any discussions with any U.S. government officials about an emergency use authorization for its coronavirus vaccine, Politico reports. The company’s statement comes a day after the Financial Times reported the White House would consider how to grant an emergency use of the AstraZeneca vaccine if a late-stage clinical trial currently taking […]

Continue Reading